Hormone sensitive protocol for metastatic prostate cancer, an update

J L Álvarez Ossorio; M Rodrigo Aliaga; A Rodríguez Antolin; M Unda Urzaiz; M Á Calleja; M de la Cruz Ruiz; J Blas Quilez; I R Hernández Millán; D Sánchez Zalabardo; J M Cozar Olmo

doi:10.1016/j.acuroe.2022.10.002

Hormone sensitive protocol for metastatic prostate cancer, an update

Actas Urol Esp (Engl Ed). 2023 May;47(4):244-249. doi: 10.1016/j.acuroe.2022.10.002. Epub 2022 Oct 18.

[Article in English, Spanish]

Authors

Affiliations

¹ Servicio de Urología, Hospital Universitario Puerta del Mar, Cádiz, Spain; Asociación Española de Urología (AEU) y Fundación para la Investigación en Urología (FIU). Electronic address: [email protected].
² Servicio de Urología, Hospital General Universitario de Castellón, Castellón, Spain.
³ Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁴ Servicio de Urología, Clínica IMQ Zorrotzaurre, Bilbao, Vizcaya, Spain.
⁵ Servicio de Farmacia Hospitalaria, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
⁶ Servicio de Urología, Hospital Son Espases, Palma de Mallorca, Baleares, Spain.
⁷ Hospital Universitario Virgen de la Salud, Complejo Hospitalario de Toledo, Toledo, Spain.
⁸ Hospital Universitario de Albacete, Albacete, Spain.
⁹ Hospital Reina Sofía, Tudela, Navarra, Spain.
¹⁰ Servicio de Urología, Hospital Universitario Virgen de las Nieves, Granada, Spain; IDI-URO (Instituto de Investigación en Urología).

PMID: 36270435
DOI: 10.1016/j.acuroe.2022.10.002

Abstract

To review and update last protocols in hormone sensitive metastatic prostate cancer for improving clinical management in routine. Evidence analysis available about recent updates protocols in hormone sensitive metastatic prostate cancer according to expert panel of clinicians about this field. A nominal consensus group for unify and improve the recommendations to the management of sensitive metastatic prostate cancer patients is currently needed. This document unifies and improve the management of patients with hormone sensitive metastatic prostate cancer, with a methodology that combines data quantitative and qualitative and based on the participation of a broad scientific committee appointed by the Spanish Association of Urology.

Keywords: Androgen deprivation therapy; Clinical follow-up; Cáncer de próstata metastásico; Hormone sensitive metastatic prostate cancer; Manejo clínico; Terapia de deprivación de andrógenos; Tratamiento; Treatment.

MeSH terms

Androgen Antagonists
Hormones
Humans
Male
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / pathology
Urology*

Substances

Androgen Antagonists
Hormones